INSPIRED TO CURE
DEAD

Serial Number

90038729

Owner

Gamida Cell Inc.

Attorney

Brendan J. Hughes

Filing Date

Jul 7, 2020

Add to watchlist:

No watchlists yet
View on USPTO

INSPIRED TO CURE Trademark

Serial Number: 90038729

INSPIRED TO CURE is a trademark filed by Gamida Cell Inc. on July 7, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Gamida Cell Inc. (21 trademarks)

780 5th Ave S
Naples, FL 34102

Entity Type: 03

Trademark Details

Filing Date

July 7, 2020

Registration Date

Not Registered

Published for Opposition

November 17, 2020

Goods & Services

Cell therapy pharmaceutical preparations; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders

Providing information regarding insurance coverage and reimbursement for prescription drugs; administration of a patient assistance program for providing prescription drugs at reduced cost

Promoting public awareness of issues related to the testing, diagnosis, treatment and patient outcome in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders; promoting the interests of patients with cancer, and blood and bone marrow diseases and disorders, by means of public advocacy

Providing educational medical information in the fields of in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders, including the testing, diagnosis, treatment and patient outcomes related thereto; Medical services, namely, providing educational information regarding prescription drugs and disease treatment; providing a call center for responding to patient and caregiver inquiries and providing educational guidance in the field of prescription pharmaceuticals and disease treatment

Research and development in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders

Filing History

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 15, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 15, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 15, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 15, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 15, 2022 COAR
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 14, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 14, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jul 9, 2021 EX1G
SOU EXTENSION 1 FILED
Jul 9, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 9, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 12, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 17, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 28, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2020 CNSA
ASSIGNED TO EXAMINER
Oct 15, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 3, 2020 NWOS
NEW APPLICATION ENTERED
Jul 10, 2020 NWAP